Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)
Description
PT2977 (Belzutifan, MK-6482), an orally active and selective inhibitor, increases potency and improves pharmacokinetic profile, providing a potential treatment for clear cell renal cell carcinoma (ccRCC).